Iranian Backstroker Raham Pieman Pieravani Gets Two-Year Suspension for Doping

FINA announced today that Iranian swimmer Raham Pieman Pieravani had been given a two-year suspension after testing positive for Letrozole (Class S.4 Hormone and Metabolic Modulators) at a swim meet on January 15, 2015.

Letrozole is a non-steroidal aromatase inhibitor that is typically used to fight breast cancer, especially after surgery, and often used for women after menopause. In layman’s terms, it is a drug that decreases the amount of estrogen the body produces, which helps combat these types of cancer.

It is also sometimes used by athletes and bodybuilders to reverse the effects of anabolic steroids, such as bloating due to excess water retention, acne, and gynecomastia.

The FINA announcement came after the completion of proceedings by the Iran National Anti-Doping Organisation, who imposed a sanction of 2 years’ ineligibility on Pieravani starting March 3, 2015.

Leave a Reply

Notify of

Inline Feedbacks
View all comments

About Anne Lepesant

Anne Lepesant

Anne Lepesant is the mother of four daughters, all of whom swam in college. With an undergraduate degree from Princeton (where she was an all-Ivy tennis player) and an MBA from INSEAD, she worked for many years in the financial industry, both in France and the U.S. Anne is currently …

Read More »